Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC

New CAR T therapy for relapsed and refractory ALL

BLIN-01: Blinatumomab for high-risk, Philadelphia chromosome-negative acute lymphoblastic leukaemia

Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours plus pembrolizumab

CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer

Phase II data from the KarMMa trial for relapsed/refractory multiple myeloma

Conducting Oncology Clinical Trials in Africa II: Twitter Workshop

Background of the KEYLYNK-007 trial for advanced solid tumours

US MM-6: Long-term proteasome inhibition in multiple myeloma following an in-class transition from bortezomib to ixazomib

Regulating haematopoietic stem cell dormancy and ageing through the netrin-1-neogenin axis

OPTIC: A dose-ranging study of 3 starting doses of ponatinib for chronic-phase chronic myeloid leukaemia

VIALE-A: Venetoclax with or without in treatment-naïve patients with acute myeloid leukaemia